The Troubling Persistence of Eugenicist Thought in Modern America
By Michael Brendan Dougherty,
The Week
| 09. 30. 2014
It's hard to shake the feeling that eugenics can make a comeback. Or that it never really left us.
When Supreme Court Justice Ruth Bader Ginsburg gave a recent interview to Elle, she let slip a statement that almost sounded like something a 1920s-style eugenicist would say. Talking about the rise of state-level restrictions on abortion, the liberal justice said, "It makes no sense as a national policy to promote birth only among poor people."
And remember, a few years ago, Ginsburg had to deny that she believed eugenic thought influenced the Supreme Court's Roe v. Wade decision. She had noted a prevailing concern about population growth at the time of the decision, "particularly growth in populations that we don't want to have too many of."
That Ginsburg had to disavow the plain meaning of her earlier words is a good sign that people are repulsed by eugenics of a certain type. We simply would not tolerate a modern Supreme Court justice with the cut of Wendell Holmes, who wrote in 1927's Buck v. Bell: "It is better...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...